xRead - Episodic Vertigo (January 2026)

10976817, 2020, S2, Downloaded from https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599820909438 by Mayo Clinic Libraries, Wiley Online Library on [19/09/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

S52

Otolaryngology–Head and Neck Surgery 162(2S)

scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol . 2006;7(2):182-193. 296. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacoki netics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope . 1999;109(7, pt 2):1-17. 297. Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applica tions. Hear Res . 2018;368:28-40. 298. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol . 2004;25(6):1034-1039. 299. Morgan AE, Ismail EI, Ashraf B. Intratympanic injections of dexamethasone in delayed endolymphatic hydrops: a prospec tive clinical study. ORL J Otorhinolaryngol Relat Spec . 2018; 80(1):19-27. 300. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwan noma). Otolaryngol Head Neck Surg . 1995;113(3):179-180. 301. Salt AN. Pharmacokinetics of drug entry into cochlear fluids. Volta Rev . 2005;105(3):277-298. 302. Bremer HG, van Rooy I, Pullens B, et al. Intratympanic gen tamicin treatment for Me´nie`re’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy—results of a prematurely ended study. Trials . 2014;15:328-328. 303. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Me´nie`re’s disease: a meta-analysis. Otol Neurotol . 2004;25(4):544-552. 304. Huon LK, Fang TY, Wang PC. Outcomes of intratympanic gentamicin injection to treat Me´nie`re’s disease. Otol Neurotol . 2012;33(5):706-714. 305. Pullens B, van Benthem PP. Intratympanic gentamicin for Me´nie`re’s disease or syndrome. Cochrane Database Syst Rev . 2011;(3):CD008234. 306. Vlastarakos PV, Iacovou E, Nikolopoulos TP. Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Me´nie`re’s disease? A critical analysis of published interventional studies. Eur Arch Otorhinolaryn gol . 2017;274(3):1309-1315. 307. Yetis x er S. Intratympanic gentamicin for intractable Me´nie`re’s disease—a review and analysis of audiovestibular impact. Int Arch Otorhinolaryngol . 2018;22(2):190-194. 308. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Me´nie`re’s disease: a meta-analysis. Laryngoscope . 2004;114(12):2085-2091. 309. Crane BT, Minor LB, Della Santina CC, Carey JP. Middle ear exploration in patients with Me´nie`re’s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol . 2009;30(5):619-624. 310. Syed MI, Ilan O, Leong AC, Pothier DD, Rutka JA. Me´nie`re’s syndrome or disease: time trends in management and quality of evidence over the last two decades. Otol Neurotol . 2015;36(8):1309-1316. 311. Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Me´nie`re’s disease. Eur Ann Otorhinolaryngol Head Neck Dis . 2018;135(1s):S29-s32.

comparative, prospective randomized 1-year control study. Egypt J Otolaryngol . 2012;28(3):171-183. 281. Patel M, Agarwal K, Arshad Q, et al. Intratympanic methyl prednisolone versus gentamicin in patients with unilateral Me´nie`re’s disease: a randomised, double-blind, comparative effectiveness trial. Lancet . 2016;388(10061):2753-2762. 282. Sarafraz M, Saki N, Nikakhlagh S, Mashali L, Arad A. Comparison the efficacy of intratympanic injections of methyl prednisolone and gentamicin to control vertigo in unilateral Me´nie`re’s disease. Biomed Pharmacol J . 2015;8:705-709. 283. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Me´nie`re’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol . 1998;19(2):196-201. 284. Syed MI, Ilan O, Nassar J, Rutka JA. Intratympanic therapy in Me´nie`re’s syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol . 2015;40(6):682-690. 285. Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Oto rhinolaryngol . 2016;273(9):2271-2278. 286. Patel M. Intratympanic corticosteroids in Me´nie`re’s disease: a mini-review. J Otol . 2017;12(3):117-124. 287. Paragache G, Panda NK, Ragunathan M, Sridhara. Intratym panic dexamethasone application in Me´nie`re’s disease—is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg . 2005;57(1):21-23. 288. Phillips JS, Westerberg B. Intratympanic steroids for Me´nie`re’s disease or syndrome. Cochrane Database Syst Rev . 2011;(7):CD008514. 289. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexa methasone inner ear perfusion by intratympanic injection in unilateral Me´nie`re’s disease: a two-year prospective, placebo controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg . 2005;133(2):285-294. 290. Chuang-Chuang A, Baeza MA. Are intratympanic corticoster oids effective for Me´nie`res disease? Medwave . 2017;17(suppl 1):e6863. 291. Albu S, Nagy A, Doros C, et al. Treatment of Me´nie`re’s dis ease with intratympanic dexamethazone plus high dosage of betahistine. Am J Otolaryngol . 2016;37(3):225-230. 292. Lambert PR, Nguyen S, Maxwell KS, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Me´nie`re’s disease. Otol Neurotol . 2012;33(7):1257-1265. 293. Lambert PR, Carey J, Mikulec AA, LeBel C. Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of Me´nie`re’s disease: randomized phase 2b safety and efficacy trial. Otol Neurotol . 2016;37(10):1669-1676. 294. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol . 2006;27(4):564-569. 295. Mynatt R, Hale SA, Gill RM, Plontke SK, Salt AN. Demonstration of a longitudinal concentration gradient along